Hot High Tech Stocks To Own Right Now

U.S. adoption of high-speed broadband connections in homes has reached an all-time high of 70% according to the Pew Research Center�� Internet & American Life Project. The survey was taken in May and is 4% higher than the previous survey in April 2012.

Education and income levels are the two factors that provide the greatest influence on broadband adoption. Some 89% of Americans with at least a college education have a broadband connection as do 88% of those with annual incomes of $75,000 or more.

Age is also a factor, with those 18 through 29 having a broadband connection rate of 80% while those 65 or older have adopted broadband at just more than half that rate, 43%. The rural adoption rate is 62%, compared with urban and suburban rates of 70% and 73%, respectively.

Broadband penetration is higher than smartphone penetration, which now stands at 56%. But including the 10% of Americans who own a smartphone but no broadband connection to those who do have broadband means that 80% of Americans have one or the other or both. Nearly half — 46% — have both, while 24% have broadband and no smartphone and 10% have only a smartphone.

Hot Media Stocks To Buy Right Now: CPFL Energia SA (CPFE3)

CPFL Energia SA is Brazil-based holding company engaged in the distribution, generation and commercialization of electric energy in Brazil. The Company is involved in the generation of electric energy through hydroelectric plants, small hydropower plants and thermoelectric power stations. Through eight distribution subsidiaries, as of December 31, 2011, it served 559 municipalities and distributed electrical energy to approximately 6.9 million clients in Brazilian states of Sao Paulo, Rio Grande do Sul, Parana and Minas Gerais. As of December 31, 2011, the Company had a number of subsidiaries, such as Companhia Paulista de Forca e Luz, Rio Grande Energia SA, CPFL Geracao de Energia SA, CPFL Comercializacao Brasil SA and CPFL Jaguariuna SA, among others. Advisors' Opinion:

• [By Patricia Lara]

  Tractebel leapfrogged Cia. Energetica de Minas Gerais, CPFL Energia SA (CPFE3) and Centrais Eletricas Brasileiras SA (ELET6) in the fourth quarter to become the biggest utility after sidestepping pressure to cut rates because its contracts don�� expire for at least 14 years. Florianopolis, Brazil-based Tractebel has gained 11 percent in the past year, less than Sabesp�� 36 percent rally, which is the most of any utility on the Bovespa index.

Hot High Tech Stocks To Own Right Now: Nintendo Co Ltd (NTDOF)

Nintendo Co., Ltd. is mainly engaged in the development, manufacture and sale of entertainment products in home entertainment field. The Company's main products include leisure machines such as portable and console game machines and software, as well as trump and Carta (Japanese-style playing cards). As of March 31, 2013, the Company had 29 subsidiaries and five associated companies. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Stocks in Japan started with losses Friday, the final session before the release of the closely watched U.S. jobs report later in the day. The Nikkei Stock Average (JP:NIK) shed 0.3% to 15,836.37, as the yen edged higher against the U.S. dollar overnight, and the broader Topix gave up 0.5%. Tech issues were mostly lower, including a 3.3% pullback in Trend Micro Inc. (JP:4704) (TMICY) , and a 2.7% decline in Nintendo Co. (JP:7974) (NTDOF) . Nintendo shares rallied Thursday after China temporarily lifted a ban on manufacturing and selling video game consoles within in the country. But among Friday's best performers were shares of Fast Retailing Co. (JP:9983) (FRCOF) , up 4.4% after the company posted a nearly 9% rise in its fiscal first-quarter net profit to 楼41.85 billion ($399 million). Sales were driven by a nearly 80% gain in Fast Retailing's overseas sales at Uniqlo stores.

• [By Parija Kavilanz]

  The retailer said the service will accept unlimited number of games for popular consoles, including Sony (SNE) Playstation, Nintendo (NTDOF)'s Wii and Microsoft's XBOX as long as they aren't damaged and are in their original packaging.

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks weakened in early Thursday trading as the yen rose and Wall Street ended mixed, with the Nikkei Stock Average (JP:NIK) falling 1.2% to 15,929.74 after a 1.9% advance a day earlier. With the yen (USDJPY) slightly firmer than in the previous session, some investors sold currency-sensitive exporters, with Fanuc Corp. (JP:6954) (FANUF) down 2%, Kyocera Corp. (JP:6971) (KYOCF) off 1.9%, and Fujitsu Ltd. (JP:6702) (FJTSY) losing 2.3%. News that China would lift a ban on some sales of videogame consoles had sent shares of Nintendo Co. (JP:7974) (NTDOF) shooting 11% higher on Wednesday, but apparent profit-taking sent the stock down 4.2% in early Thursday action. Shares of rival Sony Corp. (JP:6758) (SNE) , however, followed with a 4% rise, also possibly buoyed by a Nikkei Asian Review report that it was planning a "smartphone offensive" in the U.S. and China. Canon Inc. (JP:7751) (CAJ) fell 2% on a separate Nikkei report that the company's 2013 operating profit would miss forecasts. Toshiba Corp. (JP:6502) (TOSYY)

Hot High Tech Stocks To Own Right Now: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors' Opinion:

• [By Louis Navellier]

  Specifically, a former top scientist from Amgen (AMGN) has come aboard to cut programs that are underperforming and keep the labs focused on the biggest breakthroughs. While this won’t impact the current quarter’s numbers, if the company can beat estimates and show that it’s taking steps to bigger breakthroughs it should put additional buying pressure under the stock.

• [By Bryan Murphy]

  When most investors think of cancer stocks, names like Amgen, Inc. (NASDAQ:AMGN) or Roche Holding Ltd. (OTCMKTS:RHHBY) come to mind. And to be fair, they're both top-of-mind names for good reasons. Five of the world's top-ten selling cancer drugs are from Roche Holding, and Amgen is the world's biggest biotech company; it just spent $10 billion on the acquisition of an entire company almost to add just one cancer therapy to its library. Thing is, while Roche Holding Ltd. and Amgen, Inc. make top-notch drugs to treat cancer once acquired, neither actually does anything to prevent the development of cancer through metastasization. Indeed, the prevention of the spread of cancer isn't on the biopharma industry's radar at all, save one company - a little outfit called MetaStat Inc. (OTCBB:MTST).

• [By Daniel Putnam]

  One reason for this is the ��isk-off��environment in which institutional investors are forced to sell winners in order to raise liquidity. This puts fund-manager favorites (and big 2013 winners) such as Biogen Idec (BIIB), Amgen (AMGN) and Celgene (CELG) in the crosshairs. Further, Celgene�� earnings miss last month has depressed performance across the entire biotech sector since the news hit the wires.

Hot High Tech Stocks To Own Right Now: James Hardie Industries SE (JHX)

James Hardie Industries plc, together with its subsidiaries, manufactures and sells fiber cement products and systems for interior and exterior building construction applications primarily in the United States, Canada, Australia, New Zealand, the Philippines, and Europe. Its products principally include fiber cement interior linings, exterior siding products, and related accessories products. The company offers fiber cement products with various patterned profiles and surface finishes for a range of applications, including external siding and soffit lining, internal linings, facades, floor and tile underlay, lattice, fencing, decorative columns, flooring, and ceiling applications; and manufactures and sells fiber reinforced concrete pipes. Its products are used in various markets, such as new residential construction, which include single and multi-family housing; manufactured housing that comprise mobile and pre-fabricated homes; repair and remodeling; and various commerc ial and industrial applications, such as stores, warehouses, offices, hotels, motels, schools, libraries, museums, dormitories, hospitals, detention facilities, religious buildings, and gymnasiums. The company markets its fiber cement products and systems under various Hardie brand names, such as HardieBacker; and other brand names, such as Artisan Lap and Artisan Accent Trim by James Hardie, Cemplank and Prevail siding, Scyon, and Stria siding. The company sells its products directly, as well as through distributors, large home center retailers, small to medium size dealer outlets, and specialist distributors to dealers or lumber yards, consumers, builders, real estate developers, and distributor/hardware stores. James Hardie Industries plc was founded in 1888 and is headquartered in Dublin, the Republic of Ireland.

Advisors' Opinion:

• [By Ian Sayson]

  Exporters dropped. Samsung Electronics slipped 2.9 percent to 1.329 million won in Seoul. Canon Inc., the world�� biggest camera maker, fell 1.1 percent to 3,215 yen in Tokyo. James Hardie Industries SE (JHX), a building materials supplier that gets about 70 percent of sales from the U.S., tumbled 2.8 percent to A$9.37 in Sydney.